after taking semaglutide for Weight Loss: Before & Results Medical Weight Loss Program |

Gonzalez-OrtizMHernndez-GonzlezSOHernndez-SalazarEMartnez-AbundisE

In a two-year study, Wegovy users lost an average of 35 pounds, compared to 6 pounds in the placebo group (Managing Weight WIth Wegovy, n.d.)

E., Bell, J

Taper Off Anti-Nausea Medications As nausea resolves, reduce dependence on daily anti-nausea meds

Originally developed and approved for the management of type 2 diabetes, GLP-1 (glucagon-like peptide-1) receptor agonists have revolutionized the field of obesity medicine

Clinical experience shows that approximately 40% of patients require dose increases to 0.5mg every 3.5 days within the first 8-12 weeks of treatment